Transfusion in Sickle Cell Disease: Risk Factors for Alloimmunization

NCT03405402 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
173
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Hanane EL KENZ